
Free Daily Podcast Summary
by ATTD on UNLOK
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).Whether you're a specialist, researcher, or industry leader, hit subscribe.
The most recent episodes — sign up to get AI-powered summaries of each one.
In today’s episode, Dr Bob Gabbay is joined by Dr Elena Toschi to address the most common questions clinicians have when it comes to insulin therapy.They discuss:The most common mistakes or misconceptions in basal insulin initiation and managementIntensification strategies such as titration, adding prandial insulin, or using fixed-ratio combinationsLeveraging technologies to improve insulin adherence and outcomesManaging hypoglycemia concerns and achieving glycemic targetsAddressing psychological and behavioral barriers to insulin use in everyday clinical practiceDr Elena Toschi is Assistant Professor of Medicine at Harvard Medical School. She’s also Director of the Young Adult Program and a member of the Diabetes Technology Program at the Joslin Diabetes Center.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, Dr Bob Gabbay is joined by Dr Anne Peters to discuss personalized insulin approaches for complex populations.They discuss:Why personalization is particularly important in insulin therapyThe patient groups most in need of a tailored approachHow comorbidities or frailty influence insulin decision-makingGuidelines, flexibility, and local solutionsDr Peters is a Professor of Medicine at the Keck School of Medicine of USC, and Director of the USC Clinical Diabetes Programs.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients.They discuss:The barriers most misunderstood by cliniciansCommunication and motivational interviewing with patientsEmotional burden and fear of hypoglycemiaPractical strategies clinicians can use to support patients more effectivelyThe role of the wider diabetes healthcare teamDiana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education.They discuss:Why hypoglycemia remains a major concern in insulin therapyKey risk factors to keep in mindClinical signs or patient-reported symptomsPrevention strategiesImportance of patient educationBalancing glycemic targets with hypoglycemia riskProf. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support.They discuss:The new technologies making the biggest difference in insulin therapy todayThe role of smart pens, connected devices, and appsBiggest clinical impact - including adherence, titration and outcomesAccessibility of these tools in real-world practiceAdvisor role of AIThe promising future of technology in insulin therapy and a functional cureProfessor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations.They discuss:What exactly fixed-ratio combinations are and the problems they tackleIdentifying patient candidates and timelines for starting FRCsMeaningful benefits of FRCs compared with basal insulin aloneConcerns and limitations of FRCsHow guideline recommendations currently position FRCs in diabetes managementDr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient.They discuss:The importance of titration in successful insulin therapyBarriers to titration, including patient self-managementHow clinicians can collaborate with patients in their titration journeyThe importance of language used by cliniciansPractical tips for simplifying titration in busy clinical settingsDr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes.They discuss:When clinicians should consider insulin for patients with T2DAddressing concerns of weight gain with insulinADA/EASD recommendationsBarriers to insulin therapy and Type 2 diabetesAdvice on communication with patientsDr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals:* ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions.* Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom).Whether you're a specialist, researcher, or industry leader, hit subscribe.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from ATTD: Advanced Technologies and Treatments for Diabetes in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of ATTD: Advanced Technologies and Treatments for Diabetes as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by ATTD on UNLOK.
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
ATTD: Advanced Technologies and Treatments for Diabetes publishes daily. Our AI generates a summary within hours of each new episode.
ATTD: Advanced Technologies and Treatments for Diabetes covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.